Soliris® (Eculizumab) IV Infusion Therapy in Miami

Advanced Complement Inhibitor for Rare Blood and Neurologic Disorders

Clearwell Infusion Centers offers Soliris infusion therapy for patients diagnosed with rare, complement-mediated conditions. Located in Miami, our infusion center provides private suites, experienced nursing staff, and flexible appointment options for a safe and supportive treatment experience.

What Is Soliris?

Soliris® (eculizumab) is an FDA-approved monoclonal antibody that blocks the C5 complement protein, a part of the immune system responsible for inflammation and cell destruction in several rare diseases. By inhibiting this protein, Soliris helps reduce disease activity and prevent complications.

Soliris is administered via IV infusion every 1 to 2 weeks, depending on the treatment phase and condition being managed.

Learn more at the official Soliris website.

Conditions Treated with Soliris

Soliris is indicated for the treatment of:

• Paroxysmal Nocturnal Hemoglobinuria (PNH)
• Atypical Hemolytic Uremic Syndrome (aHUS)
• Generalized Myasthenia Gravis (gMG) in anti-AChR antibody-positive adults
• Neuromyelitis Optica Spectrum Disorder (NMOSD) in anti-AQP4 antibody-positive adults

Soliris is typically prescribed by specialists when other therapies are insufficient or when rapid disease control is needed.

Soliris Side Effects

Soliris is generally well tolerated but may carry serious risks, including:

• Headache
• Upper respiratory tract infections
• Nausea or vomiting
• Infusion-related reactions
• Increased risk of meningococcal infections (vaccination required)

Clearwell follows ACHC-accredited protocols for infusion safety, including premedication and close monitoring during and after treatment.

View full prescribing and safety information at the Soliris Prescribing Information.

Why Choose Clearwell for Your Soliris Infusion?

Clearwell Infusion Centers is designed for comfort, safety, and efficiency. When you receive Soliris at our Miami location, you benefit from:

• Private treatment suites with spa-like amenities
• Low patient-to-nurse ratio for attentive care
• Flexible appointment times, including weekends and evenings
• Comprehensive insurance coordination, including prior authorizations and benefits checks
• ACHC-accredited facility and safety standards
• Close coordination with your prescribing provider and care team

Soliris infusions typically last about 35 minutes to 2 hours, depending on dosing and patient tolerance.

Getting Started with Soliris

If your specialist has prescribed Soliris, Clearwell will manage all aspects of treatment setup—from insurance approvals to appointment scheduling and post-infusion care.

Call 305‑306‑7147 or email contact@clearwellinfusion.com to start your Soliris therapy today.

Referring Providers: Partner with Clearwell Infusion Centers

Clearwell Infusion Centers collaborates with hematologists, neurologists, and nephrologists to provide safe and reliable administration of Soliris in an outpatient setting.

Why refer to Clearwell?

• Fast insurance verification and prior auth turnaround
• Streamlined referral and intake process
• Timely documentation and infusion summaries sent to your office
• Experienced clinical team familiar with complement inhibitors
• ACHC-accredited safety protocols for rare disease therapy

To refer a patient for Soliris IV therapy in Miami, contact our provider team at referrals@clearwellinfusion.com or call 305‑306‑7147.

Looking to start your Stelara treatment at Clearwell Infusion Centers?

Fill out the form below and a member of our team will contact you